与整体恶化相比,生物学药物在减少喘相关住院病例的比较有效性的较小差异
Ayobami Akenroye1, James Marshall2, Andrew L Simon2
1Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Mass; Department of Medicine, Harvard Medical School, Boston, Mass.
概括
杜皮卢马布显示了最低的整体喘恶化,而梅波利祖马布导致呼吸道生物使用者少入院. 这些发现比较了奥马利祖马布,梅波利祖马布,本拉利祖马布和杜比卢马布的有效性.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 现实世界的证据.
背景情况:
- 呼吸道生物制剂在喘中的比较有效性数据有限.
- 生物药物如奥马利祖马布,梅波利祖马布,本拉利祖马布和杜比卢马布针对严重的喘.
- 了解现实世界的比较结果对于临床决策至关重要.
研究的目的:
- 为了比较四种呼吸系统生物药物的有效性:奥马利祖马布,梅波利祖马布,本拉利祖马布和杜皮卢马布.
- 在现实世界患者队列中评估喘相关的恶化和住院.
- 为了评估倾向性得分匹配的患者组的结果.
主要方法:
- 使用行政索赔数据进行回顾性队列研究 (FDA Sentinel,Merative MarketScan).
- 包括18岁或以上的患者开始使用奥马利祖马布,梅波利祖马布,本拉利祖马布或杜皮卢马布 (2018年11月至2023年6月).
- 倾向性得分匹配和负二项式回归用于比较结果.
主要成果:
- 杜皮卢马布的使用与整体喘恶化发病率最低有关.
- 梅波利祖马布和本拉利祖马布的喘相关住院病例发生率最低.
- 杜皮卢马布在患有并发鼻多重症的患者中更频繁地使用.
结论:
- 杜皮卢马布显示出最低的整体恶化率,而梅波利祖马布与最少的喘住院病例有关.
- 潜在的残留混因素,如基线乙氨基酸细胞计数,可能会影响观察到的差异.
- 现实世界的数据为喘生物药物的比较有效性提供了宝贵的见解.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
294
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
294
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
264
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
264
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
246
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
246
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
01:24Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K